RFA: K12 Paul Calabresi Award for Clinical Oncology

March 21, 2022

The DF/HCC K12 Internal Advisory Committee is seeking applications for the K12 Paul Calabresi Award for Clinical Oncology, entitled “Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical Oncology.” Funding for at least one new Scholar will be available, retroactive to April 1, 2022. Senior fellows and junior faculty, within three years of their first appointment, are eligible, provided they do not hold R01 or equivalent funding. The deadline for applications is Friday April 15, 2022.

The overall mission of the DF/HCC K12 Program is to identify the most talented trainees in our academic community and prepare them for careers in translational oncology research through didactic and practical experience in clinical investigation that is closely linked to laboratory research (including “wet” and “dry” lab). This K12 Program is designed exclusively for physicians (MD or MD/PhD) who have completed subspecialty clinical training in adult or pediatric hematology/oncology, or radiation oncology. Each scholar must identify a Basic Science Mentor and a Clinical Science Mentor. Additional mentors from any DF/HCC institution, as well as the Broad and Koch Institutes, may be recruited to supply content-specific advice or assistance if their expertise is not well-represented in the core DF/HCC K12 faculty.

Scholar salaries can be requested up to $100,000, in accordance with K-awardee salary guidelines, along with associated fringe benefits. The total salary requested for Scholars must be established on the base salary of a full-time, 12-month staff appointment. Scholars are required to devote a minimum of 9 person months of full-time professional effort to conducting health-related research. Each appointment’s annual direct costs must not exceed $138,888. A modified total direct cost F&A rate of 8% is allowable. The performance period is April 1, 2022, through March 31, 2023. The program provides Scholars 3-5 years of support (contingent on available funds, continued Scholar eligibility, and a successful renewal), although at this time only one year is guaranteed since we are in a renewal cycle.

An application consists of the following components:

  • Research Plan (5 pages maximum) 
  • Plan for Didactic Coursework (1 page) and Mentorship Plan (1 page)
  • Letters of Support (Institutional Support, Clinical Mentor, Laboratory Mentor) 
  • Budget & Justification and Biosketches (Applicant and Mentors)

Minority and women applicants are strongly encouraged to apply. Additional information may be obtained by contacting the Program Administrator, Kelsey Laning (klaning@mgh.harvard.edu).